Catheter Ablation of Atrial Fibrillation in Heart Failure: from Evidences to Guidelines

Curr Heart Fail Rep. 2021 Jun;18(3):153-162. doi: 10.1007/s11897-021-00508-z. Epub 2021 Apr 4.

Abstract

Purpose of review: Catheter ablation of atrial fibrillation in heart failure seems to be the way to improve the quality of life, life expectance, and prognosis. In this review, we outline the growing role of this therapy and which patients can benefit from it.

Recent findings: While previous studies comparing rate control and rhythm control had not demonstrated the superiority of rhythm control in the prognosis of patients with atrial fibrillation and heart failure, recent findings seem to demonstrate that catheter ablation of atrial fibrillation reduces mortality and hospitalization for heart failure and improves the quality of life, when compared to medical therapy alone. An early rhythm-control strategy in atrial fibrillation may reduce cardiovascular death, stroke, hospitalization for HF, or acute coronary syndrome. Catheter ablation in heart failure is an effective and safe solution to obtain a rhythm control and, therefore, to improve outcomes. A better selection of the patients could help to avoid futile procedures and to identify patients requiring a closer follow-up, to redo procedures, or the addition of antiarrhythmic drugs.

Keywords: Atrial fibrillation; Catheter ablation; Heart failure.

Publication types

  • Review

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / surgery
  • Catheter Ablation*
  • Heart Failure* / complications
  • Heart Failure* / surgery
  • Humans
  • Quality of Life

Substances

  • Anti-Arrhythmia Agents